ARAIX
Price
$77.63
Change
-$0.72 (-0.92%)
Updated
Feb 3 closing price
Net Assets
2.73B
MVCAX
Price
$31.51
Change
-$0.46 (-1.44%)
Updated
Feb 3 closing price
Net Assets
17.11B
Interact to see
Advertisement

ARAIX vs MVCAX

Header iconARAIX vs MVCAX Comparison
Open Charts ARAIX vs MVCAXBanner chart's image
Ariel Fund Institutional
Price$77.63
Change-$0.72 (-0.92%)
VolumeN/A
Net Assets2.73B
MFS Mid Cap Value A
Price$31.51
Change-$0.46 (-1.44%)
VolumeN/A
Net Assets17.11B
ARAIX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
ARAIX vs. MVCAX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAIX is a Hold and MVCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.1B vs. ARAIX (2.73B). MVCAX pays higher dividends than ARAIX: MVCAX (1.20) vs ARAIX (0.11). ARAIX was incepted earlier than MVCAX: ARAIX (14 years) vs MVCAX (24 years). MVCAX (1.00) is less costly to investors than ARAIX (0.69). MVCAX is a more actively managed with annual turnover of: 24.00 vs. ARAIX (17.00). MVCAX has a lower initial minimum investment than ARAIX: MVCAX (1000) vs ARAIX (1000000). ARAIX annual gain was more profitable for investors over the last year : 6.50 vs. MVCAX (1.90). MVCAX return over 5 years is better than : 23.95 vs. ARAIX (9.54).
ARAIXMVCAXARAIX / MVCAX
Total Expense Ratio0.690.9970%
Annual Report Gross Expense Ratio0.691.0069%
Fund Existence14 years24 years-
Gain YTD6.2484.789130%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.73B17.1B16%
Annual Yield % from dividends0.111.209%
Returns for 1 year6.501.90343%
Returns for 3 years9.0811.1382%
Returns for 5 years9.5423.9540%
Returns for 10 years62.3599.0963%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX51.170.44
+0.87%
Eventide Healthcare & Life Sciences N
FGETX25.40N/A
N/A
Fidelity Advisor Glbl Capital Apprec M
JMCCX58.29-0.09
-0.15%
JPMorgan Mid Cap Equity C
AQGIX12.48-0.07
-0.56%
AQR Global Equity I
MSHNX12.87-0.28
-2.13%
Morgan Stanley Inst Permanence A